|
 "EU Health Commissioner Stella Kyriakides announced during our (EU
lawmakers) group meeting this morning that the vaccine manufacturer
Johnson & Johnson is likely to submit an application for approval to
the EU for their vaccine in February," said Peter Liese, who
represents health matters for the EU's centre-right group, the
assembly's largest.
The EU drugs regulator had said in December it expected the company
to apply in the first quarter of this year.
The European Medicines Agency started on Dec. 1 a rolling review of
the vaccine, which Johnson & Johnson is developing through its
subsidiary Janssen.
[to top of second column] |
The EU has booked 200 million doses of the J&J vaccine and has an
option to order another 200 million shots. The J&J jab is monodose,
unlike other vaccines approved so far in the EU and which require
two doses for full protection.
(Reporting by Francesco Guarascio @fraguarascio; editing by Jason
Neely and Louise Heavens)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
